Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Other financing activities (2016 - 2025)

Healthstream (HSTM) has disclosed Other financing activities for 12 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 629.28% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 126.06% year-over-year, with the annual reading at $2.5 million for FY2025, 126.06% up from the prior year.
  • Other financing activities for Q4 2025 was $1.3 million at Healthstream, up from $121000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.3 million in Q4 2025, with the low at -$711000.0 in Q4 2021.
  • Average Other financing activities over 5 years is $207684.2, with a median of $20000.0 recorded in 2023.
  • Peak annual rise in Other financing activities hit 700.0% in 2023, while the deepest fall reached 89.2% in 2023.
  • Over 5 years, Other financing activities stood at -$711000.0 in 2021, then soared by 252.32% to $1.1 million in 2022, then tumbled by 89.2% to $117000.0 in 2023, then surged by 54.7% to $181000.0 in 2024, then soared by 629.28% to $1.3 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $1.3 million, $121000.0, and $5000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.